Synaptogenix (TAOX) Stock Chart & Stock Price History $7.65 +1.20 (+18.60%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock Synaptogenix Stock Price Performance The Synaptogenix (TAOX) stock chart highlights key performance trends across multiple timeframes. As of the latest close, Synaptogenix traded at $6.45 with a market cap of $8.97 million and volume of 104,568 shares. Receive TAOX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.93% TAOX Stock Chart for Friday, August, 22, 2025 TAOX Chart by TradingView Synaptogenix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$6.45$7.65+18.60%$7.88$6.40337,606 shs$10.63 million08/21/2025$6.93$6.45-6.93%$7.31$6.39104,568 shs$8.97 million08/20/2025$6.96$6.93-0.43%$7.39$6.56180,718 shs$9.63 million08/19/2025$8.34$6.96-16.55%$8.52$6.55360,499 shs$9.67 million08/18/2025$8.40$8.34-0.71%$8.73$8.09199,794 shs$11.59 million08/15/2025$9.19$8.40-8.60%$9.31$8.10249,502 shs$11.68 million08/14/2025$9.56$9.19-3.87%$9.40$8.51374,351 shs$12.77 million08/13/2025$8.34$9.56+14.63%$9.75$8.41463,660 shs$13.29 million08/12/2025$7.39$8.34+12.86%$8.57$7.15421,122 shs$11.59 million08/11/2025$6.16$7.39+19.97%$7.96$6.18612,087 shs$10.27 million Get the Latest News and Ratings for TAOX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$5.95$6.16+3.53%$6.45$5.86216,151 shs$8.56 million08/07/2025$6.22$5.95-4.34%$6.65$5.56327,911 shs$8.27 million08/06/2025$5.89$6.22+5.60%$6.59$5.65258,987 shs$8.65 million08/05/2025$6.49$5.89-9.24%$6.61$5.50240,512 shs$8.19 million08/04/2025$5.99$6.49+8.35%$6.70$5.78211,958 shs$9.02 million08/01/2025$6.33$5.99-5.37%$6.25$5.70232,576 shs$8.33 million07/31/2025$6.74$6.33-6.08%$7.15$6.31183,037 shs$8.80 million07/30/2025$6.86$6.74-1.75%$7.42$6.65135,499 shs$9.37 million07/29/2025$6.52$6.86+5.21%$7.00$6.23205,610 shs$9.54 million07/28/2025$8.41$6.52-22.47%$8.82$6.51412,835 shs$9.06 million Related Companies Alterity Therapeutics Stock Price Chart Kalaris Therapeutics Stock Price Chart Nabriva Therapeutics Stock Price Chart Grace Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Enlivex Therapeutics Stock Price Chart Sol-Gel Technologies Stock Price Chart 180 Life Sciences Stock Price Chart Acrivon Therapeutics Stock Price Chart Generation Bio Stock Price Chart Receive TAOX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TAOX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access